Our team helps you launch and streamline even the most challenging studies. Let our experts identify and monitor the sites where you can reach your target population of interest.
Tell us your study specifications, and we’ll strategically select and onboard clinical sites, negotiate contracts, and continuously monitor compliance to maximize trial success.
We have IRB / IEC / MOH-approved collection protocols in-place for over 90 disease states. These approvals allow you to avoid the costly delays typically associated with obtaining new regulatory clearances, accelerating study start-up, and the overall timeline of the clinical trial.
Whether you are launching a single-site study for a rare disease or a multi-site trial for a prevalent cancer, we have the sites and expertise to power your early-phase development through approval.
We follow stringent data security protocols, including compliance with HIPAA and GDPR, to uphold the privacy and security of all trial data.
We use targeted recruitment strategies and ongoing patient engagement to ensure optimal enrollment and retention rates, minimizing dropout and maximizing trial completion.
With experience working with international governing agencies, we navigate complex regulatory requirements to help you get your innovations to market faster.
We oversee final data collection and site audits to meet regulatory and documentation requirements, facilitating a successful trial closure.
Oncology
Rare diseases
Infectious diseases
Cardiovascular
Gastrointestinal
Autoimmune
Neurodegenerative
And more…
IRB documentation review and revision
IRB fee facilitation
Handling of IRB / IEC / MOH submissions
Controlling study management costs
Contract negotiation with investigator/site
Contract administration
Translation of patient-facing materials
Preparation of training materials for site staff
Preparation of collection kits
Shipment of study materials and supplies
IP and inventory management
Weekly update meetings
Regulatory file preparation
Site regulatory document verification
Compliance oversight
TMF maintenance
Electronic Data Capture (EDC)
Study development and configuration
Electronic Case Report Form (eCRF) design
eCRF validation
Study testing and validation
EDC user setup for site staff
Importation of study-specific IDs
EDC user training prep and conduct
Data extraction
Preparation of sponsor data file
EDC system administration
Preparation of monitoring plan
Pre-study qualification visit
Site initiation visit
Interim monitoring visits
Monitoring report draft and review
Ongoing remote monitoring
Closeout visit
We partner with your scientists who are passionate about developing solutions that improve patients' lives. With Boca Bio, your team gets the necessary cancer specimens, services, and data to develop therapies, companion diagnostics, biologics, and novel cell and gene therapies. Let us support the development of your next precision oncology breakthrough.
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Boca Bio offers a complement of clinical research services, including site and collection management, data capture, and coordination to ensure your pre-clinical and discovery studies run seamlessly to achieve desired milestones. We offer end-to-end services, so you don’t have to manage the details.
Yes, Boca Bio maintains compliance with all IRB approvals in place for our U.S. sites, as well as ethics committee/MOH approval for all international sites.
One of the advantages of using Boca Bio is that we have established IRB/ethics committee/MOH approvals in place for your projects. Some IRB/ethics committee/MOH approval processes can take weeks or months, depending on the site and location. If a protocol approval is not in place, then an application will be submitted to the IRB/ethics committee/MOH.
We have a global footprint of 120+ collection sites worldwide, in over 60 countries.
Yes, we can provide monitoring services for your research study. We conduct a site initiation visit, interim monitoring visits, and a project close-out visit.
Yes. From initial concept to market approval or study closure, our team ensures comprehensive project and site management throughout every phase of your project.
Our site and project management approach combines meticulous planning, continuous monitoring, and effective communication, ensuring projects stay on track and within budget.
